Jove
Visualize
Contact Us

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

BetaDescribe: Providing rich descriptions from protein sequences.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Cancer frenemy pathways: Inducing immunogenic cell death by exploiting apoptosis-interferon antagonism with oncolytic viruses.

Molecular therapy. Oncology·2026
Same author

Induction of caspase-mediated suppression of interferon signaling potentiates viral oncolysis of resistant tumor cells.

Cell communication and signaling : CCS·2026
Same author

cJun-N-terminal kinase activity and mitosis perturbation drive the 2-methoxyestradiol-mediated enhancement of viral oncolysis by Epizootic Hemorrhagic Disease Virus-Tel Aviv University.

Scientific reports·2025
Same author

The snakehead retrovirus promoter functions independently of the 3'ORF protein and its products are maternally inherited in transgenic zebrafish.

PLoS pathogens·2025
Same author

Dual signaling pathways of TGF-β superfamily cytokines in hepatocytes: balancing liver homeostasis and disease progression.

Frontiers in pharmacology·2025
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 14, 2026

Long-term Live-cell Imaging to Assess Cell Fate in Response to Paclitaxel
08:29

Long-term Live-cell Imaging to Assess Cell Fate in Response to Paclitaxel

Published on: May 14, 2018

9.8K

Nuclear Morphology-Based Assessment of Cell Fates Induced by a Microtubule Targeting Agent as a Single Treatment or

Sucheta De1, Marcelo Ehrlich2

  • 1Shmunis School of Biomedicine and Cancer Research, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel.

Methods in Molecular Biology (Clifton, N.J.)
|April 23, 2025
PubMed
Summary

This study presents a new method using immunofluorescence microscopy to analyze how 2-methoxestradiol (2ME2) affects bladder cancer cells. The technique helps assess combined treatments with microtubule agents and oncolytic viruses for cancer therapy.

Keywords:
Fluorescence microscopyMicrotubule targeting agentMitotic slippageNuclear morphometryOncolytic virus

More Related Videos

Assessing Cell Viability and Death in 3D Spheroid Cultures of Cancer Cells
10:33

Assessing Cell Viability and Death in 3D Spheroid Cultures of Cancer Cells

Published on: June 16, 2019

27.1K
Live Cell Imaging to Assess the Dynamics of Metaphase Timing and Cell Fate Following Mitotic Spindle Perturbations
07:14

Live Cell Imaging to Assess the Dynamics of Metaphase Timing and Cell Fate Following Mitotic Spindle Perturbations

Published on: September 20, 2019

8.1K

Related Experiment Videos

Last Updated: Jun 14, 2026

Long-term Live-cell Imaging to Assess Cell Fate in Response to Paclitaxel
08:29

Long-term Live-cell Imaging to Assess Cell Fate in Response to Paclitaxel

Published on: May 14, 2018

9.8K
Assessing Cell Viability and Death in 3D Spheroid Cultures of Cancer Cells
10:33

Assessing Cell Viability and Death in 3D Spheroid Cultures of Cancer Cells

Published on: June 16, 2019

27.1K
Live Cell Imaging to Assess the Dynamics of Metaphase Timing and Cell Fate Following Mitotic Spindle Perturbations
07:14

Live Cell Imaging to Assess the Dynamics of Metaphase Timing and Cell Fate Following Mitotic Spindle Perturbations

Published on: September 20, 2019

8.1K

Area of Science:

  • Cell Biology
  • Cancer Research
  • Microscopy

Background:

  • Single-cell analysis is crucial for understanding heterogeneous cell populations.
  • Average parameter values can obscure distinct subpopulation states.
  • Immunofluorescence microscopy offers quantitative, single-cell resolution for cell fate assessment.

Purpose of the Study:

  • To develop a methodology for characterizing the effects of 2-methoxestradiol (2ME2) on T24 human bladder cancer cells.
  • To identify and classify cells undergoing mitosis or mitotic slippage.
  • To evaluate the potential of combined treatments with microtubule targeting agents and oncolytic viruses.

Main Methods:

  • Utilized immunofluorescence microscopy for quantitative cell fate assessment.
  • Assessed nuclear morphology, DNA content, and microtubule distribution patterns.
  • Combined with imaging for cells expressing oncolytic virus proteins (e.g., EHDV-TAU).

Main Results:

  • Characterized the effects of 2ME2 on T24 human bladder cancer cells at single-cell resolution.
  • Identified cells in mitosis and mitotic slippage based on morphological and molecular markers.
  • Demonstrated a method to assess combined therapeutic strategies.

Conclusions:

  • Immunofluorescence microscopy is effective for detailed cell fate analysis in heterogeneous cancer cell populations.
  • The described methodology can evaluate combined treatments involving microtubule agents and oncolytic viruses.
  • This approach aids in developing novel cancer therapies.